Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leibowitz

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
ACS Synthetic Biology|May 2, 2025
Engineered Feedback Employing Natural Hypoxia-Responsive Factors Enhances Synthetic Hypoxia BiosensorsKathleen S Dreyer, Patrick S Donahue, Jonathan D Boucher, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Design and synthesis of fluorinated RXR modulatorsD L Gernert, R Ajamie, R A Ardecky, et al.
Endocrinology|January 26, 2008
LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivoFrancisco J López, Robert J Ardecky, Bruce Bebo, et al.
The Journal of Biological Chemistry|April 19, 1996
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db miceB Zhang, M P Graziano, T W Doebber, et al.
FEBS Letters|May 20, 2000
Activation of PPARdelta alters lipid metabolism in db/db miceM D Leibowitz, C Fiévet, N Hennuyer, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profilePierre-Yves Michellys, Marcus F Boehm, Jyun-Hung Chen, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acidsPierre-Yves Michellys, Robert J Ardecky, Jyun-Hung Chen, et al.
The Journal of Biological Chemistry|February 26, 1999
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effectsJ Berger, M D Leibowitz, T W Doebber, et al.
Nature Biotechnology|October 2, 2019
Integrated genomic profiling expands clinical options for patients with cancerNike Beaubier, Martin Bontrager, Robert Huether, et al.
Clinical Breast Cancer|January 15, 2021
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing DataLouis E Fernandes, Caroline G Epstein, Alexandria M Bobe, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
ACS Synthetic Biology|May 2, 2025
Engineered Feedback Employing Natural Hypoxia-Responsive Factors Enhances Synthetic Hypoxia BiosensorsKathleen S Dreyer, Patrick S Donahue, Jonathan D Boucher, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Design and synthesis of fluorinated RXR modulatorsD L Gernert, R Ajamie, R A Ardecky, et al.
Endocrinology|January 26, 2008
LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivoFrancisco J López, Robert J Ardecky, Bruce Bebo, et al.
The Journal of Biological Chemistry|April 19, 1996
Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db miceB Zhang, M P Graziano, T W Doebber, et al.
FEBS Letters|May 20, 2000
Activation of PPARdelta alters lipid metabolism in db/db miceM D Leibowitz, C Fiévet, N Hennuyer, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Design and synthesis of novel RXR-selective modulators with improved pharmacological profilePierre-Yves Michellys, Marcus F Boehm, Jyun-Hung Chen, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acidsPierre-Yves Michellys, Robert J Ardecky, Jyun-Hung Chen, et al.
The Journal of Biological Chemistry|February 26, 1999
Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effectsJ Berger, M D Leibowitz, T W Doebber, et al.
Nature Biotechnology|October 2, 2019
Integrated genomic profiling expands clinical options for patients with cancerNike Beaubier, Martin Bontrager, Robert Huether, et al.
Clinical Breast Cancer|January 15, 2021
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing DataLouis E Fernandes, Caroline G Epstein, Alexandria M Bobe, et al.
Pageof 10